Is dantrolene effective in heat stroke patients?
- 1 March 1990
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 18 (3), 290-292
- https://doi.org/10.1097/00003246-199003000-00009
Abstract
Dantrolene (2.45 mg/kg body weight, range 2 to 4) was administered iv in eight heat stroke (HS) patients and compared with a control group of 12 patients of similar age, weight, and temperature range (41.9° to 44°C). Body surface cooling was conducted in air conditioned rooms at temperatures of 18° to 23°C. Mean cooling time in the dantrolene group was 49.7 ± 4.4 (SEM) min, whereas cooling time in the control group was 69.2 ± 4.8 min. The decrease in temperature was significantly greater in the dantrolene group, for whom the cooling time was decreased by about 19.5 min (p < .01). Although cooling time was significantly shorter in the dantrolene group, there was no difference in the recovery of both groups. Dantrolene is an expensive drug and justification for its routine use in HS remains to be evaluated.This publication has 4 references indexed in Scilit:
- Heat stroke at the Mekkah pilgrimage: clinical characteristics and course of 30 patients.1986
- Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case reportAmerican Journal of Psychiatry, 1982
- Dantrolene in Human Malignant Hyperthermia A Multicenter StudyAnesthesiology, 1982
- A PHYSIOLOGICAL BODY-COOLING UNIT FOR TREATMENT OF HEAT STROKEThe Lancet, 1980